Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D for chemotherapy-induced fever and neutropenia in children with malignancy
IRCT20240608062045N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Dec 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of vitamin d in febrile neutropenia (FN), sponsored by Arak University of Medical Sciences. Started Dec 2022; status: completed.
02
Drugs
vitamin d
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on IRCT20240608062045N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240608062045N1.